Results 31 to 40 of about 21,695 (218)

Design and testing of hydrophobic core/hydrophilic shell nano/micro particles for drug-eluting stent coating [PDF]

, 2018
In this study, we designed a novel drug-eluting coating for vascular implants consisting of a core coating of the anti-proliferative drug docetaxel (DTX) and a shell coating of the platelet glycoprotein IIb/IIIa receptor monoclonal antibody SZ-21.
A Arsiwala, A Bierhalz, A Tan, AW Heldman, B Almería, B O’brien, B O’Brien, C Stettler, CJ Pan, CJ Sweeney, CL Song, D Sun, DM Saylor, E Boersma, E Camenzind, ES Park, ES Thian, F Danhier, GY An, H Zhang, HG Wang, J Kanzer, J Riegger, J Yang, J Zhang, JB Slee, JJ Wykrzykowska, JM Lee, JV Natarajan, K Kolandaivelu, KH Bønaa, KS Lim, M Gawaz, M Zamani, M Zamani, MK Dong, MP Skinner, MT Ali, PS Douglas, PW Erruys, RH Müller, RK Aggarwal, RL Wilensky, S Freiberg, S Garg, S Hossfeld, S Jang, S Lee, S Mcginty, S Meng, S Puricel, S Yasuda, SJ Liu, T Inoue, T Nakano, TM Ko, U Baber, X Ma, X Wu, X Xi, Y Cao, YH Lee, Z Yang   +62 more
core   +1 more source

Drug-Eluting Stents and Balloons—Materials, Structure Designs, and Coating Techniques: A Review

Molecules, 2020
Controlled drug delivery is a matter of interest to numerous scientists from various domains, as well as an essential issue for society as a whole. In the treatment of many diseases, it is crucial to control the dosing of a drug for a long time and thus ...
I. Rykowska, I. Nowak, R. Nowak
doaj   +1 more source

The current state of endovascular intervention for critical limb ischemia: A systematic review

Vascular Investigation and Therapy, 2021
The treatment of critical limb ischemia (CLI) has long been a “hot spot” in medical science. It is widely believed that revascularization is the cornerstone of CLI therapy.
Hongxiao Wu, Pin Ye, Yunfei Chen, Yiqing Li, Chuanqi Cai, Ping Lv   +5 more
doaj   +1 more source

Short Term Outcome of Drug Eluting Balloon for Percutaneous Coronary Intervention

Pakistan Armed Forces Medical Journal, 2023
Objective: To assess the short-term outcome of Drug Eluting Balloon (DEB) for Percutaneous Coronary Intervention (PCI).   Study Design: Analytical Cross-sectional study   Place and Duration of Study: Armed Forces Institute of Cardiology/National ...
Maida Anwar, Asif Nadeem, Fahad Ur Rehman, Sana Sarfraz, Iftikhar Ahmed, Naseem Azad, Muhamad Bilal Siddique, Javeria Kamran   +7 more
doaj   +1 more source

ESVM Guideline on peripheral arterial disease [PDF]

, 2019
International ...
, , , Belch, Jill, Boc, Vinko, Brodmann, Marianne, Bulvas, Miroslav, Canning, Caitriona, Carpentier, Patrick H., Chraim, Ali, Colgan, Mary-Paula, Dimakakos, Evangelos, Dorigo, Walter, Frank, Ulrich, Gottsäter, Anders, Heiss, Christian, Houston, Graeme, Kahan, Thomas, Lawall, Holger, Lindstedt, Isak, Madaric, Juraj, Mahe, Guillaume, Martini, Romeo, Mazzolai, Lucia, Nikol, Sigrid, Olinic, Dan Mircea, Pernod, Giles, Poredoš, Pavel, Przywara, Stanislaw, Pécsvárady, Zsolt, Quéré, Isabelle, Righini, Marc, Roztocil, Karel, Schlager, Oliver, Stanek, Agata, Terlecki, Piotr, Vasic, Dragan, Visonà, Adriana, Wautrecht, Jean-Claude   +38 more
core   +5 more sources

Drug-Coated Balloon-Only Strategy for De Novo Coronary Artery Disease: A Meta-analysis of Randomized Clinical Trials

Cardiovascular Therapeutics, 2023
Backgrounds. Many clinical trials have demonstrated the value of drug-coated balloons (DCB) for in-stent restenosis. However, their role in de novo lesions is not well documented.
Wenyi Zhang, Mingduo Zhang, Jinfan Tian, Min Zhang, Yuan Zhou, Xiantao Song   +5 more
doaj   +1 more source

Drug-Eluting Balloons and Drug-Eluting Stents in the Treatment of Peripheral Vascular Disease [PDF]

Seminars in Interventional Radiology, 2018
AbstractIn the last 20 years, peripheral artery disease (PAD) has been increasingly recognized as a significant cause of morbidity and mortality in the United States. The endovascular treatment of PAD has seen a marked rise as minimally invasive techniques and devices have been refined.
Jonathan, Lindquist, Kristofer, Schramm
openaire   +2 more sources

Clinical outcomes of percutaneous coronary intervention for de novo lesions in small coronary arteries: A systematic review and network meta-analysis

Frontiers in Cardiovascular Medicine, 2022
BackgroundPercutaneous coronary intervention (PCI) has a well-established role in revascularization for coronary artery disease. We performed network meta-analysis to provide evidence on optimal intervention strategies for de novo lesions in small ...
Wen-Rui Ma, Karthik H. Chandrasekharan, Chang-Sheng Nai, Yong-Xiang Zhu, Javaid Iqbal, Shang Chang, You-Wei Cheng, Xin-Yu Wang, Christos V. Bourantas, Yao-Jun Zhang   +9 more
doaj   +1 more source

Revascularization for coronary artery disease in diabetes mellitus: Angioplasty, stents and coronary artery bypass grafting [PDF]

, 2010
Author Manuscript: 2011 April 14Patients with diabetes mellitus (DM) are prone to a diffuse and rapidly progressive form of atherosclerosis, which increases their likelihood of requiring revascularization.
A Abizaid, A Abizaid, A Bayes-Genis, A Dibra, A Kapur, A Kastrati, A Kastrati, AM Freeman, AS Morss, B Lagerqvist, B Stein, BJ Hoogwerf, BJ Rensing, BR Chaitman, C Berry, C Berry, C Rask-Madsen, C Stettler, C Stettler, D Aronson, D Aronson, D Aronson, D Choi, D Hasdai, DE Cutlip, DE Cutlip, DJ Holmes, Doron Aronson, E Belle Van, E Belle Van, EL Alderman, Elazer R. Edelman, FG Welt, GN Levine, H Osanai, HC Gerstein, I Iakovou, I Moussa, J Aoki, J Daemen, J Daemen, J Machecourt, J Schofer, JA Colwell, JB Hermiller, JD Flaherty, JL Orford, JP Carrozza Jr, K Esposito, KE Kip, KE Kip, KH Mak, KM Detre, L Schwartz, L Zhang, LH Young, LO Jensen, M Jonas, M Sabate, MA Hlatky, ME Farkouh, ME Pfisterer, MG Vandormael, MN Babapulle, N Marx, NE West, P Gum, P Piatti, P Urban, P Wenaweser, PJ Quigley, PW Serruys, R Kornowski, R Seabra-Gomes, R Takeda, RA Corpus, RL Frye, S Elezi, S Goldberg, S Roy, S Windecker, SB King 3rd, SB King 3rd, SB King 3rd, SC Smith Jr, SD Wiviott, SM Haffner, T Sakaguchi, T Takagi, TA Trikalinos, TF Luscher, TF Luscher, The Bypass Angioplasty Revascularization Investigation (BARI), The Bypass Angioplasty Revascularization Investigation (BARI) Investigators, V Legrand, W Weintraub, WE Boden, WE Boden, Y Nishimoto   +98 more
core   +1 more source

Zotarolimus-eluting stent fracture at initial implantation diagnosed with StentBoost

SAGE Open Medical Case Reports, 2016
Stent fracture is a rare complication of drug-eluting stent implantation with a reported rate of 0.84%–3.2% in various clinical studies with first-generation drug-eluting stents and 29% in autopsy studies.
Alev Arat Ozkan, Umit Yasar Sinan, Aziz T Gurmen   +2 more
doaj   +1 more source